Related Experiment Video

Updated: Jul 19, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

45.6K

Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024

Monica M Lahra1,2, Sonya Natasha Hutabarat1, Tiffany R Hogan1

  • 1The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia.

Communicable Diseases Intelligence (2018)
|November 20, 2024
PubMed

Insights

The Australian Meningococcal Surveillance Programme (AMSP) tracks invasive meningococcal disease (IMD) cases and serogroups. Since 2024, reports also include antimicrobial resistance data for key antibiotics.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Invasive meningococcal disease (IMD) remains a significant public health concern.
  • Effective surveillance is crucial for monitoring disease trends and informing public health interventions.

Purpose of the Study:

  • To report on the number of laboratory-confirmed invasive meningococcal disease (IMD) cases in Australia.
  • To provide updated data on serogroup distribution and antimicrobial resistance patterns.

Main Methods:

  • Laboratory confirmation of IMD cases using culture and molecular techniques.
  • Data collection and reporting through the Australian Meningococcal Surveillance Programme (AMSP).
  • Inclusion of antimicrobial resistance data for ceftriaxone, penicillin, ciprofloxacin, and rifampicin from 2024.

Main Results:

  • Quarterly reports detail IMD case numbers by jurisdiction and serogroup.
  • Expanded 2024 data includes antimicrobial resistance profiles for key antibiotics.
  • Annual reports provide comprehensive analysis of laboratory confirmations.

Conclusions:

  • The AMSP provides essential data for understanding the epidemiology of IMD in Australia.
  • The inclusion of antimicrobial resistance data enhances the programme's utility for guiding treatment strategies.
  • Continued surveillance is vital for tracking changes in IMD and informing prevention efforts.

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

21.8K
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.2K

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...